Genmab — Januar 2025
-
Johnson & Johnson's Quarterly Earnings Preview: What You Need to Know https://proinvestor.com/investornyt/1260997/johnson-amp-johnsons-quarterly-earnings-preview-what-you-need-to-know
-
Porter...Der er chattet meget omkring emnet. Jeg forslår at du scroller ned gennem chathistorikken.
-
Lad os håbe, at Klimovsky tænker på aktionærerne, når hun ser frem til 2025 som et “rewarding” year https://www.linkedin.com/posts/judith-klimovsky-0859549_happyholidays-activity-7275894692842545155-3F83?utm_source=share&utm_medium=member_ios Meget lang tid siden insidere har solgt.
-
Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference https://proinvestor.com/investornyt/1261237/genmab-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference
-
Nytårsudgaven af ØU Formue med 15 Vinderaktier er på gaden: Genmab kan fordoble kursen i 1. kvartal https://ugebrev.dk/formue/oversigt-den-udvidede-nytaarsudgave-af-oeu-formue-genmab-kan-fordoble-kursen-i-1-kvartal/
-
That would be very nice
-
*God
-
I næste uge går det altså for alvor løs med konferencen d. 14.!
-
small new trial - Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders PTLD - https://clinicaltrials.gov/study/NCT06672705
-
Vitus - den analyse sad sgu ikke lige skabet
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind